WATSON 415 (Estropipate 1.5 mg)
Pill imprint WATSON 415 has been identified as Estropipate 1.5 mg.
Estropipate is used in the treatment of atrophic urethritis; postmenopausal symptoms; primary ovarian failure; osteoporosis; oophorectomy (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 415 (Estropipate 1.5 mg)
Estropipate
- Imprint:
-
WATSON 415
- Strength:
- 1.5 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
More resources
Estropipate is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
